3 results

  • akynzeo

    (Netupitant and Palonosetron)
    Helsinn Therapeutics (U.S.), Inc.
    AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing cancer chemotherapy, particularly highly emetogenic regimens. It is used in combination with dexamethasone and consists of palonosetron and netupitant (or fosnetupitant in the injection form).

  • aloxi

    (palonosetron hydrochloride)
    Helsinn Therapeutics (U.S.), Inc.
    ALOXI capsules are indicated for adults to prevent acute nausea and vomiting linked to initial and repeat courses of moderately emetogenic cancer chemotherapy.

  • valchlor

    (mechlorethamine hydrochloride)
    Helsinn Therapeutics (U.S.), Inc.
    VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have previously undergone skin-directed therapy.